cd25 antibody, anti-human, reafinity (Miltenyi Biotec)
Miltenyi Biotec is a verified supplier 
Miltenyi Biotec manufactures this product 
93
Structured Review
Miltenyi Biotec
cd25 antibody, anti-human, reafinity
Cd25 Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 76 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd25/CD25+Antibody%2C+anti-human%2C+REAfinity/custom%40130-122-302%4042526444
Average 93 stars, based on 76 article reviews
Cd25 Antibody, Anti Human, Reafinity, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 76 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd25/CD25+Antibody%2C+anti-human%2C+REAfinity/custom%40130-122-302%4042526444
Average 93 stars, based on 76 article reviews
cd25 antibody, anti-human, reafinity - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Labeling:Article Title: Lipoic acid improves wound healing through its immunomodulatory and anti-inflammatory effects in a diabetic mouse model. Article Snippet: 1 Cell Biology Department, Biotechnology Research Institute, National Research Centre, Dokki, Giza 12622, Egypt 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Salman International University, Ras Sudr, South Sinai, Egypt 3 Hormones Department, Medical Research and Clinical Studies Institute, and Stem Cell Lab, Center of Excellence for Advanced Sciences, National Research Centre, Dokki, Cairo 12622, Egypt 4 Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O.. BOX 84428, 11671 Riyadh, Saudi Arabia 5 Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia 6 Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Cairo 11829, Egypt Abstract Objectives Diabetes mellitus is a chronic disease that has become more prevalent worldwide because of lifestyle changes.. It leads to serious complications, including increased atherosclerosis, protein glycosylation, endothelial dysfunction, and vascular denervation. Bioprocessing:Article Title: Lipoic acid improves wound healing through its immunomodulatory and anti-inflammatory effects in a diabetic mouse model. Article Snippet: 1 Cell Biology Department, Biotechnology Research Institute, National Research Centre, Dokki, Giza 12622, Egypt 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Salman International University, Ras Sudr, South Sinai, Egypt 3 Hormones Department, Medical Research and Clinical Studies Institute, and Stem Cell Lab, Center of Excellence for Advanced Sciences, National Research Centre, Dokki, Cairo 12622, Egypt 4 Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O.. BOX 84428, 11671 Riyadh, Saudi Arabia 5 Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia 6 Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Cairo 11829, Egypt Abstract Objectives Diabetes mellitus is a chronic disease that has become more prevalent worldwide because of lifestyle changes.. It leads to serious complications, including increased atherosclerosis, protein glycosylation, endothelial dysfunction, and vascular denervation. Article Title: Systemic miR-26a deficiency attenuates pulmonary fibrosis via PTEN upregulation and downstream TIMP-1 suppression Article Snippet: .. Cells were treated with TruStain FcX (93, BioLegend) followed by staining with fluorochrome-conjugated antibodies or biotinylated monoclonal antibodies CD19 (clone 6D5), B220 (clone RA3-6B2), IgD (clone 11-26c.2a), IgM (clone RMM-1), CD5 (clone 53–7.3), CD21 (clone 7E9), CD38 (clone 90), CD73 (clone TY/11.8), CD138 (clone 281–2), and TACI (clone 8F10) from BioLegend; CD23 (clone B3B4) from Invitrogen; Article Title: Systemic miR-26a deficiency attenuates pulmonary fibrosis via PTEN upregulation and downstream TIMP-1 suppression Article Snippet: .. Cells were treated with TruStain FcX (93, BioLegend) followed by staining with fluorochrome-conjugated antibodies or biotinylated monoclonal antibodies CD19 (clone 6D5), B220 (clone RA3-6B2), IgD (clone 11-26c.2a), IgM (clone RMM-1), CD5 (clone 53–7.3), CD21 (clone 7E9), CD38 (clone 90), CD73 (clone TY/11.8), CD138 (clone 281–2), and TACI (clone 8F10) from BioLegend; CD23 (clone B3B4) from Invitrogen; Blocking Assay:Article Title: Lipoic acid improves wound healing through its immunomodulatory and anti-inflammatory effects in a diabetic mouse model. Article Snippet: 1 Cell Biology Department, Biotechnology Research Institute, National Research Centre, Dokki, Giza 12622, Egypt 2 Department of Pharmacology and Toxicology, Faculty of Pharmacy, King Salman International University, Ras Sudr, South Sinai, Egypt 3 Hormones Department, Medical Research and Clinical Studies Institute, and Stem Cell Lab, Center of Excellence for Advanced Sciences, National Research Centre, Dokki, Cairo 12622, Egypt 4 Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, P.O.. BOX 84428, 11671 Riyadh, Saudi Arabia 5 Department of Biology, College of Science, Imam Mohammad Ibn Saud Islamic University, Riyadh 11623, Saudi Arabia 6 Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Badr University in Cairo (BUC), Badr City, Cairo 11829, Egypt Abstract Objectives Diabetes mellitus is a chronic disease that has become more prevalent worldwide because of lifestyle changes.. It leads to serious complications, including increased atherosclerosis, protein glycosylation, endothelial dysfunction, and vascular denervation. Staining:Article Title: Systemic miR-26a deficiency attenuates pulmonary fibrosis via PTEN upregulation and downstream TIMP-1 suppression Article Snippet: .. Cells were treated with TruStain FcX (93, BioLegend) followed by staining with fluorochrome-conjugated antibodies or biotinylated monoclonal antibodies CD19 (clone 6D5), B220 (clone RA3-6B2), IgD (clone 11-26c.2a), IgM (clone RMM-1), CD5 (clone 53–7.3), CD21 (clone 7E9), CD38 (clone 90), CD73 (clone TY/11.8), CD138 (clone 281–2), and TACI (clone 8F10) from BioLegend; CD23 (clone B3B4) from Invitrogen; Article Title: A novel Vδ1 engager targeting CD19 enhances human Vδ1 γδ T cell responses against CLL and CD19+ hematological malignancies. Article Snippet: γδ T cells are associated with favorable outcomes in many cancers likely through a mechanism of stress-directed cytotoxicity and antitumor cytokine production.. Vδ1 γδ T cells are especially promising for immunotherapy due to their broad stress recognition and resistance to activation-induced cell death.. Here, we generate a CD19 engager incorporating a novel Vδ1 binding moiety as proof-of-concept for treating CD19 cancers, including Chronic Lymphocytic Leukemia (CLL). Article Title: Systemic miR-26a deficiency attenuates pulmonary fibrosis via PTEN upregulation and downstream TIMP-1 suppression Article Snippet: .. Cells were treated with TruStain FcX (93, BioLegend) followed by staining with fluorochrome-conjugated antibodies or biotinylated monoclonal antibodies CD19 (clone 6D5), B220 (clone RA3-6B2), IgD (clone 11-26c.2a), IgM (clone RMM-1), CD5 (clone 53–7.3), CD21 (clone 7E9), CD38 (clone 90), CD73 (clone TY/11.8), CD138 (clone 281–2), and TACI (clone 8F10) from BioLegend; CD23 (clone B3B4) from Invitrogen; Article Title: Multispecific anti-TCR delta variable 1 antibodies Article Snippet: Skin γδ T-cells (from donor ATS006) were seeded into a 96 well round bottom plate at 6×10{circumflex over ( )}5 cells/ml in γδ media with THP-1 cells (ATCC®-TIB-202) at 1.2×10{circumflex over ( )}6 cells/ml and increasing concentration of the test mAbs (range from 0.00067 to 67 nM) or the highest concentration (67 nM) of the corresponding isotype control (higG1, RSV), diluted in PBS. .. The cells were incubated for 24 hours in a humidified CO2 chamber at 37° C. The cells were washed and stained for dead cells (THERMO FISHERTM) #15580607), VD1 TCRs (MILTENYI® #130-117-697) and Article Title: Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells Article Snippet: .. 1x10 5 cells per condition were used for cell surface marker staining for CXCR4 (APC, Miltenyi Biotec, #130-120-708 [clone REA649]), CD4 (PE, Miltenyi Biotec, #130-113-225 [clone REA623]), Article Title: Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells. Article Snippet: .. 1x105 cells per condition were used for cell surface marker staining for CXCR4 (APC, Miltenyi Biotec, #130-120-708 [clone REA649]), CD4 (PE, Miltenyi Biotec, #130-113-225 [clone REA623]), Flow Cytometry:Article Title: A novel Vδ1 engager targeting CD19 enhances human Vδ1 γδ T cell responses against CLL and CD19+ hematological malignancies. Article Snippet: γδ T cells are associated with favorable outcomes in many cancers likely through a mechanism of stress-directed cytotoxicity and antitumor cytokine production.. Vδ1 γδ T cells are especially promising for immunotherapy due to their broad stress recognition and resistance to activation-induced cell death.. Here, we generate a CD19 engager incorporating a novel Vδ1 binding moiety as proof-of-concept for treating CD19 cancers, including Chronic Lymphocytic Leukemia (CLL). Incubation:Article Title: Multispecific anti-TCR delta variable 1 antibodies Article Snippet: Skin γδ T-cells (from donor ATS006) were seeded into a 96 well round bottom plate at 6×10{circumflex over ( )}5 cells/ml in γδ media with THP-1 cells (ATCC®-TIB-202) at 1.2×10{circumflex over ( )}6 cells/ml and increasing concentration of the test mAbs (range from 0.00067 to 67 nM) or the highest concentration (67 nM) of the corresponding isotype control (higG1, RSV), diluted in PBS. .. The cells were incubated for 24 hours in a humidified CO2 chamber at 37° C. The cells were washed and stained for dead cells (THERMO FISHERTM) #15580607), VD1 TCRs (MILTENYI® #130-117-697) and FACS:Article Title: Multispecific anti-TCR delta variable 1 antibodies Article Snippet: Skin γδ T-cells (from donor ATS006) were seeded into a 96 well round bottom plate at 6×10{circumflex over ( )}5 cells/ml in γδ media with THP-1 cells (ATCC®-TIB-202) at 1.2×10{circumflex over ( )}6 cells/ml and increasing concentration of the test mAbs (range from 0.00067 to 67 nM) or the highest concentration (67 nM) of the corresponding isotype control (higG1, RSV), diluted in PBS. .. The cells were incubated for 24 hours in a humidified CO2 chamber at 37° C. The cells were washed and stained for dead cells (THERMO FISHERTM) #15580607), VD1 TCRs (MILTENYI® #130-117-697) and Isolation:Article Title: Teriflunomide Inhibits Human FOXP3 + Regulatory T Cell Function by Interference With Mitochondrial Respiration. Article Snippet: In brief, PBMCswere isolated by Ficoll-Paque PLUS (GE17-1440-02, Sigma) gradient centrifugation. .. Marker:Article Title: Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells Article Snippet: .. 1x10 5 cells per condition were used for cell surface marker staining for CXCR4 (APC, Miltenyi Biotec, #130-120-708 [clone REA649]), CD4 (PE, Miltenyi Biotec, #130-113-225 [clone REA623]), Article Title: Alternative polyadenylation upon CPSF6 knock-out enhances HIV-1 infection in primary T cells. Article Snippet: .. 1x105 cells per condition were used for cell surface marker staining for CXCR4 (APC, Miltenyi Biotec, #130-120-708 [clone REA649]), CD4 (PE, Miltenyi Biotec, #130-113-225 [clone REA623]), |
